nitric oxide donor
An agent, with unique chemical structure and biochemical requirements, which generates nitric oxide.
|
|
soluble guanylate cyclase activator
Any compound that binds to and activates soluble guanylate cyclase (EC 4.6.1.2).
|
|
geroprotector
Any compound that supports healthy aging, slows the biological aging process, or extends lifespan.
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
vasodilator agent
A drug used to cause dilation of the blood vessels.
|
|
4-phenyl-1,2,5-oxadiazole-3-carbonitrile 2-oxide
|
2-oxo-4-phenyl-1,2,5λ5-oxadiazole-3-carbonitrile
|
IUPAC
|
3-cyano-4-phenylfurazan 2-oxide
|
ChEBI
|
RVC-589
|
ChEBI
|